VictoryShares US EQ Income Enhanced Volatility Wtd ETF

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, PONAX has a market cap of 229.5B. Regarding current trading prices, CDC is priced at $71.08, while PONAX trades at $10.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas PONAX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to PONAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PONAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check PONAX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, PONPX has a market cap of 228.4B. Regarding current trading prices, CDC is priced at $71.08, while PONPX trades at $10.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas PONPX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to PONPX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PONPX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check PONPX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, PIMIX has a market cap of 228.4B. Regarding current trading prices, CDC is priced at $71.08, while PIMIX trades at $10.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas PIMIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to PIMIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PIMIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check PIMIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, CWIAX has a market cap of 149.4B. Regarding current trading prices, CDC is priced at $71.08, while CWIAX trades at $71.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas CWIAX's P/E ratio is 23.45. In terms of profitability, CDC's ROE is +0.00%, compared to CWIAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to CWIAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check CWIAX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, CWGFX has a market cap of 149.4B. Regarding current trading prices, CDC is priced at $71.08, while CWGFX trades at $71.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas CWGFX's P/E ratio is 23.45. In terms of profitability, CDC's ROE is +0.00%, compared to CWGFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to CWGFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check CWGFX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, CWGIX has a market cap of 149.4B. Regarding current trading prices, CDC is priced at $71.08, while CWGIX trades at $71.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas CWGIX's P/E ratio is 23.45. In terms of profitability, CDC's ROE is +0.00%, compared to CWGIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to CWGIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check CWGIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, RIDGX has a market cap of 149.2B. Regarding current trading prices, CDC is priced at $71.08, while RIDGX trades at $26.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas RIDGX's P/E ratio is 19.18. In terms of profitability, CDC's ROE is +0.00%, compared to RIDGX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to RIDGX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check RIDGX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, AMECX has a market cap of 149.2B. Regarding current trading prices, CDC is priced at $71.08, while AMECX trades at $26.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas AMECX's P/E ratio is 19.17. In terms of profitability, CDC's ROE is +0.00%, compared to AMECX's ROE of +0.09%. Regarding short-term risk, CDC is more volatile compared to AMECX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check AMECX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, IFAFX has a market cap of 147.8B. Regarding current trading prices, CDC is priced at $71.08, while IFAFX trades at $26.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas IFAFX's P/E ratio is 19.16. In terms of profitability, CDC's ROE is +0.00%, compared to IFAFX's ROE of +0.09%. Regarding short-term risk, CDC is more volatile compared to IFAFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check IFAFX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, RWICX has a market cap of 146.9B. Regarding current trading prices, CDC is priced at $71.08, while RWICX trades at $70.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas RWICX's P/E ratio is 23.44. In terms of profitability, CDC's ROE is +0.00%, compared to RWICX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to RWICX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check RWICX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, RIRGX has a market cap of 128.1B. Regarding current trading prices, CDC is priced at $71.08, while RIRGX trades at $78.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas RIRGX's P/E ratio is 19.68. In terms of profitability, CDC's ROE is +0.00%, compared to RIRGX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to RIRGX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check RIRGX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, CIRAX has a market cap of 128.1B. Regarding current trading prices, CDC is priced at $71.08, while CIRAX trades at $78.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas CIRAX's P/E ratio is 19.67. In terms of profitability, CDC's ROE is +0.00%, compared to CIRAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to CIRAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check CIRAX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, CIBFX has a market cap of 127B. Regarding current trading prices, CDC is priced at $71.08, while CIBFX trades at $78.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas CIBFX's P/E ratio is 19.67. In terms of profitability, CDC's ROE is +0.00%, compared to CIBFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to CIBFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check CIBFX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, CAIBX has a market cap of 126.7B. Regarding current trading prices, CDC is priced at $71.08, while CAIBX trades at $78.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas CAIBX's P/E ratio is 19.67. In terms of profitability, CDC's ROE is +0.00%, compared to CAIBX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to CAIBX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check CAIBX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, DODIX has a market cap of 108B. Regarding current trading prices, CDC is priced at $71.08, while DODIX trades at $12.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas DODIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to DODIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to DODIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check DODIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, FKINX has a market cap of 86.1B. Regarding current trading prices, CDC is priced at $71.08, while FKINX trades at $2.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas FKINX's P/E ratio is 20.45. In terms of profitability, CDC's ROE is +0.00%, compared to FKINX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to FKINX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check FKINX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, FNCFX has a market cap of 85.8B. Regarding current trading prices, CDC is priced at $71.08, while FNCFX trades at $2.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas FNCFX's P/E ratio is 20.45. In terms of profitability, CDC's ROE is +0.00%, compared to FNCFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to FNCFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check FNCFX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, VEIPX has a market cap of 65.8B. Regarding current trading prices, CDC is priced at $71.08, while VEIPX trades at $44.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas VEIPX's P/E ratio is 15.22. In terms of profitability, CDC's ROE is +0.00%, compared to VEIPX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to VEIPX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check VEIPX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, VEIRX has a market cap of 65.8B. Regarding current trading prices, CDC is priced at $71.08, while VEIRX trades at $94.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas VEIRX's P/E ratio is 15.23. In terms of profitability, CDC's ROE is +0.00%, compared to VEIRX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to VEIRX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check VEIRX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, VWIAX has a market cap of 49B. Regarding current trading prices, CDC is priced at $71.08, while VWIAX trades at $61.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas VWIAX's P/E ratio is 15.82. In terms of profitability, CDC's ROE is +0.00%, compared to VWIAX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to VWIAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check VWIAX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, VWINX has a market cap of 48.8B. Regarding current trading prices, CDC is priced at $71.08, while VWINX trades at $25.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas VWINX's P/E ratio is 15.82. In terms of profitability, CDC's ROE is +0.00%, compared to VWINX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to VWINX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check VWINX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, HLIEX has a market cap of 44B. Regarding current trading prices, CDC is priced at $71.08, while HLIEX trades at $25.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas HLIEX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to HLIEX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HLIEX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check HLIEX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JEPI has a market cap of 44B. Regarding current trading prices, CDC is priced at $71.08, while JEPI trades at $57.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JEPI's P/E ratio is 26.62. In terms of profitability, CDC's ROE is +0.00%, compared to JEPI's ROE of +0.00%. Regarding short-term risk, CDC is less volatile compared to JEPI. This indicates potentially lower risk in terms of short-term price fluctuations for CDC.Check JEPI's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, OIEJX has a market cap of 43.6B. Regarding current trading prices, CDC is priced at $71.08, while OIEJX trades at $25.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas OIEJX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to OIEJX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to OIEJX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check OIEJX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, LDLVX has a market cap of 43B. Regarding current trading prices, CDC is priced at $71.08, while LDLVX trades at $3.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas LDLVX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to LDLVX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to LDLVX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check LDLVX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, LLDYX has a market cap of 42.9B. Regarding current trading prices, CDC is priced at $71.08, while LLDYX trades at $3.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas LLDYX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to LLDYX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to LLDYX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check LLDYX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JPST has a market cap of 37.5B. Regarding current trading prices, CDC is priced at $71.08, while JPST trades at $50.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JPST's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JPST's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to JPST. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JPST's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, VTINX has a market cap of 36.7B. Regarding current trading prices, CDC is priced at $71.08, while VTINX trades at $13.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas VTINX's P/E ratio is 22.31. In terms of profitability, CDC's ROE is +0.00%, compared to VTINX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to VTINX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check VTINX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JEPQ has a market cap of 33.9B. Regarding current trading prices, CDC is priced at $71.08, while JEPQ trades at $56.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JEPQ's P/E ratio is 32.72. In terms of profitability, CDC's ROE is +0.00%, compared to JEPQ's ROE of +0.00%. Regarding short-term risk, CDC is less volatile compared to JEPQ. This indicates potentially lower risk in terms of short-term price fluctuations for CDC.Check JEPQ's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, AHTFX has a market cap of 27.4B. Regarding current trading prices, CDC is priced at $71.08, while AHTFX trades at $9.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas AHTFX's P/E ratio is 48.62. In terms of profitability, CDC's ROE is +0.00%, compared to AHTFX's ROE of -0.09%. Regarding short-term risk, CDC is more volatile compared to AHTFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check AHTFX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, PRFDX has a market cap of 25B. Regarding current trading prices, CDC is priced at $71.08, while PRFDX trades at $38.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas PRFDX's P/E ratio is 19.72. In terms of profitability, CDC's ROE is +0.00%, compared to PRFDX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PRFDX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check PRFDX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, TIBIX has a market cap of 24.8B. Regarding current trading prices, CDC is priced at $71.08, while TIBIX trades at $35.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas TIBIX's P/E ratio is 4.37. In terms of profitability, CDC's ROE is +0.00%, compared to TIBIX's ROE of +0.01%. Regarding short-term risk, CDC is more volatile compared to TIBIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check TIBIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, TIBMX has a market cap of 24.8B. Regarding current trading prices, CDC is priced at $71.08, while TIBMX trades at $35.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas TIBMX's P/E ratio is 4.37. In terms of profitability, CDC's ROE is +0.00%, compared to TIBMX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TIBMX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check TIBMX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, TIBGX has a market cap of 24.7B. Regarding current trading prices, CDC is priced at $71.08, while TIBGX trades at $35.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas TIBGX's P/E ratio is 4.34. In terms of profitability, CDC's ROE is +0.00%, compared to TIBGX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TIBGX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check TIBGX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, TIBAX has a market cap of 24.7B. Regarding current trading prices, CDC is priced at $71.08, while TIBAX trades at $35.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas TIBAX's P/E ratio is 4.34. In terms of profitability, CDC's ROE is +0.00%, compared to TIBAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TIBAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check TIBAX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, TIBRX has a market cap of 24.6B. Regarding current trading prices, CDC is priced at $71.08, while TIBRX trades at $35.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas TIBRX's P/E ratio is 4.33. In terms of profitability, CDC's ROE is +0.00%, compared to TIBRX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TIBRX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check TIBRX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, TIBCX has a market cap of 24.6B. Regarding current trading prices, CDC is priced at $71.08, while TIBCX trades at $35.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas TIBCX's P/E ratio is 4.33. In terms of profitability, CDC's ROE is +0.00%, compared to TIBCX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TIBCX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check TIBCX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, GAIFX has a market cap of 22.6B. Regarding current trading prices, CDC is priced at $71.08, while GAIFX trades at $21.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas GAIFX's P/E ratio is 24.46. In terms of profitability, CDC's ROE is +0.00%, compared to GAIFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to GAIFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check GAIFX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, MIAWX has a market cap of 21.7B. Regarding current trading prices, CDC is priced at $71.08, while MIAWX trades at $9.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas MIAWX's P/E ratio is 54.89. In terms of profitability, CDC's ROE is +0.00%, compared to MIAWX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to MIAWX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check MIAWX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, IGIFX has a market cap of 20.2B. Regarding current trading prices, CDC is priced at $71.08, while IGIFX trades at $45.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas IGIFX's P/E ratio is 18.17. In terms of profitability, CDC's ROE is +0.00%, compared to IGIFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to IGIFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check IGIFX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, PFIAX has a market cap of 18.4B. Regarding current trading prices, CDC is priced at $71.08, while PFIAX trades at $8.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas PFIAX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to PFIAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PFIAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check PFIAX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, PFIIX has a market cap of 18.4B. Regarding current trading prices, CDC is priced at $71.08, while PFIIX trades at $8.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas PFIIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to PFIIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PFIIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check PFIIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, VGIAX has a market cap of 17.5B. Regarding current trading prices, CDC is priced at $71.08, while VGIAX trades at $105.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas VGIAX's P/E ratio is 22.13. In terms of profitability, CDC's ROE is +0.00%, compared to VGIAX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to VGIAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check VGIAX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, VQNPX has a market cap of 17.2B. Regarding current trading prices, CDC is priced at $71.08, while VQNPX trades at $64.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas VQNPX's P/E ratio is 22.13. In terms of profitability, CDC's ROE is +0.00%, compared to VQNPX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to VQNPX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check VQNPX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, PRXEX has a market cap of 17.1B. Regarding current trading prices, CDC is priced at $71.08, while PRXEX trades at $7.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas PRXEX's P/E ratio is 32.88. In terms of profitability, CDC's ROE is +0.00%, compared to PRXEX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PRXEX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check PRXEX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, PRCIX has a market cap of 17.1B. Regarding current trading prices, CDC is priced at $71.08, while PRCIX trades at $7.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas PRCIX's P/E ratio is 32.88. In terms of profitability, CDC's ROE is +0.00%, compared to PRCIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PRCIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check PRCIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, ESIIX has a market cap of 16.7B. Regarding current trading prices, CDC is priced at $71.08, while ESIIX trades at $6.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas ESIIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to ESIIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to ESIIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check ESIIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, BLPFX has a market cap of 16.7B. Regarding current trading prices, CDC is priced at $71.08, while BLPFX trades at $19.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas BLPFX's P/E ratio is 23.54. In terms of profitability, CDC's ROE is +0.00%, compared to BLPFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to BLPFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check BLPFX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, COSIX has a market cap of 16.4B. Regarding current trading prices, CDC is priced at $71.08, while COSIX trades at $21.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas COSIX's P/E ratio is 24.88. In terms of profitability, CDC's ROE is +0.00%, compared to COSIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to COSIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check COSIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, FADMX has a market cap of 15.6B. Regarding current trading prices, CDC is priced at $71.08, while FADMX trades at $12.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas FADMX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FADMX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to FADMX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check FADMX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, FAGIX has a market cap of 15.2B. Regarding current trading prices, CDC is priced at $71.08, while FAGIX trades at $10.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas FAGIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FAGIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to FAGIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check FAGIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, FGRIX has a market cap of 14.6B. Regarding current trading prices, CDC is priced at $71.08, while FGRIX trades at $67.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas FGRIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FGRIX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to FGRIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check FGRIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, FLTMX has a market cap of 14.4B. Regarding current trading prices, CDC is priced at $71.08, while FLTMX trades at $10.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas FLTMX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FLTMX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to FLTMX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check FLTMX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, ABHFX has a market cap of 14.3B. Regarding current trading prices, CDC is priced at $71.08, while ABHFX trades at $15.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas ABHFX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to ABHFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to ABHFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check ABHFX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, FFRHX has a market cap of 14.1B. Regarding current trading prices, CDC is priced at $71.08, while FFRHX trades at $8.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas FFRHX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FFRHX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to FFRHX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check FFRHX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, ACEIX has a market cap of 13B. Regarding current trading prices, CDC is priced at $71.08, while ACEIX trades at $11.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas ACEIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to ACEIX's ROE of -0.30%. Regarding short-term risk, CDC is more volatile compared to ACEIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check ACEIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, HBLRX has a market cap of 11.7B. Regarding current trading prices, CDC is priced at $71.08, while HBLRX trades at $14.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas HBLRX's P/E ratio is 20.57. In terms of profitability, CDC's ROE is +0.00%, compared to HBLRX's ROE of -0.12%. Regarding short-term risk, CDC is more volatile compared to HBLRX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check HBLRX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, HBLTX has a market cap of 11.7B. Regarding current trading prices, CDC is priced at $71.08, while HBLTX trades at $14.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas HBLTX's P/E ratio is 20.57. In terms of profitability, CDC's ROE is +0.00%, compared to HBLTX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HBLTX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check HBLTX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, HBLVX has a market cap of 11.6B. Regarding current trading prices, CDC is priced at $71.08, while HBLVX trades at $14.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas HBLVX's P/E ratio is 20.58. In terms of profitability, CDC's ROE is +0.00%, compared to HBLVX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HBLVX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check HBLVX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, TSIIX has a market cap of 10.4B. Regarding current trading prices, CDC is priced at $71.08, while TSIIX trades at $11.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas TSIIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to TSIIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TSIIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check TSIIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JSOAX has a market cap of 9.6B. Regarding current trading prices, CDC is priced at $71.08, while JSOAX trades at $11.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JSOAX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JSOAX's ROE of +0.10%. Regarding short-term risk, CDC is more volatile compared to JSOAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JSOAX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, INPFX has a market cap of 9.5B. Regarding current trading prices, CDC is priced at $71.08, while INPFX trades at $14.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas INPFX's P/E ratio is 22.00. In terms of profitability, CDC's ROE is +0.00%, compared to INPFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to INPFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check INPFX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, DFCF has a market cap of 9.5B. Regarding current trading prices, CDC is priced at $71.08, while DFCF trades at $42.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas DFCF's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to DFCF's ROE of +0.00%. Regarding short-term risk, CDC is less volatile compared to DFCF. This indicates potentially lower risk in terms of short-term price fluctuations for CDC.Check DFCF's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, FEQIX has a market cap of 9.4B. Regarding current trading prices, CDC is priced at $71.08, while FEQIX trades at $86.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas FEQIX's P/E ratio is 20.20. In terms of profitability, CDC's ROE is +0.00%, compared to FEQIX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to FEQIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check FEQIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, PQIAX has a market cap of 8.3B. Regarding current trading prices, CDC is priced at $71.08, while PQIAX trades at $41.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas PQIAX's P/E ratio is 22.13. In terms of profitability, CDC's ROE is +0.00%, compared to PQIAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PQIAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check PQIAX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, FEQTX has a market cap of 8.3B. Regarding current trading prices, CDC is priced at $71.08, while FEQTX trades at $30.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas FEQTX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FEQTX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to FEQTX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check FEQTX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, FETKX has a market cap of 8.3B. Regarding current trading prices, CDC is priced at $71.08, while FETKX trades at $30.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas FETKX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FETKX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to FETKX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check FETKX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JDNAX has a market cap of 8.2B. Regarding current trading prices, CDC is priced at $71.08, while JDNAX trades at $69.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JDNAX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JDNAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JDNAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JDNAX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JDNRX has a market cap of 8.1B. Regarding current trading prices, CDC is priced at $71.08, while JDNRX trades at $68.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JDNRX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JDNRX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JDNRX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JDNRX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JGINX has a market cap of 8.1B. Regarding current trading prices, CDC is priced at $71.08, while JGINX trades at $69.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JGINX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JGINX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JGINX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JGINX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JDNNX has a market cap of 8.1B. Regarding current trading prices, CDC is priced at $71.08, while JDNNX trades at $69.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JDNNX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JDNNX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JDNNX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JDNNX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JADGX has a market cap of 8.1B. Regarding current trading prices, CDC is priced at $71.08, while JADGX trades at $69.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JADGX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JADGX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JADGX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JADGX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JAGIX has a market cap of 8.1B. Regarding current trading prices, CDC is priced at $71.08, while JAGIX trades at $69.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JAGIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JAGIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JAGIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JAGIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JGICX has a market cap of 8.1B. Regarding current trading prices, CDC is priced at $71.08, while JGICX trades at $67.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JGICX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JGICX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JGICX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JGICX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, NSTLX has a market cap of 8B. Regarding current trading prices, CDC is priced at $71.08, while NSTLX trades at $10.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas NSTLX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to NSTLX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to NSTLX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check NSTLX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, SPYI has a market cap of 7.9B. Regarding current trading prices, CDC is priced at $71.08, while SPYI trades at $50.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas SPYI's P/E ratio is 26.73. In terms of profitability, CDC's ROE is +0.00%, compared to SPYI's ROE of +0.00%. Regarding short-term risk, CDC is less volatile compared to SPYI. This indicates potentially lower risk in terms of short-term price fluctuations for CDC.Check SPYI's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, HFQSX has a market cap of 7.8B. Regarding current trading prices, CDC is priced at $71.08, while HFQSX trades at $7.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas HFQSX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to HFQSX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HFQSX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check HFQSX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, HFQRX has a market cap of 7.8B. Regarding current trading prices, CDC is priced at $71.08, while HFQRX trades at $7.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas HFQRX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to HFQRX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HFQRX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check HFQRX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, HFQIX has a market cap of 7.8B. Regarding current trading prices, CDC is priced at $71.08, while HFQIX trades at $7.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas HFQIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to HFQIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HFQIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check HFQIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, HFQAX has a market cap of 7.8B. Regarding current trading prices, CDC is priced at $71.08, while HFQAX trades at $7.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas HFQAX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to HFQAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HFQAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check HFQAX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, HFQTX has a market cap of 7.8B. Regarding current trading prices, CDC is priced at $71.08, while HFQTX trades at $7.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas HFQTX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to HFQTX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HFQTX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check HFQTX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, HFQCX has a market cap of 7.8B. Regarding current trading prices, CDC is priced at $71.08, while HFQCX trades at $7.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas HFQCX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to HFQCX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HFQCX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check HFQCX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, PDI has a market cap of 7.3B. Regarding current trading prices, CDC is priced at $71.08, while PDI trades at $17.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas PDI's P/E ratio is 7.44. In terms of profitability, CDC's ROE is +0.00%, compared to PDI's ROE of +0.11%. Regarding short-term risk, CDC is less volatile compared to PDI. This indicates potentially lower risk in terms of short-term price fluctuations for CDC.Check PDI's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, CPXAX has a market cap of 7.3B. Regarding current trading prices, CDC is priced at $71.08, while CPXAX trades at $12.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas CPXAX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to CPXAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to CPXAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check CPXAX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, CGCP has a market cap of 7.2B. Regarding current trading prices, CDC is priced at $71.08, while CGCP trades at $22.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas CGCP's P/E ratio is 10.89. In terms of profitability, CDC's ROE is +0.00%, compared to CGCP's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to CGCP. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check CGCP's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, DLFNX has a market cap of 6.9B. Regarding current trading prices, CDC is priced at $71.08, while DLFNX trades at $9.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas DLFNX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to DLFNX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to DLFNX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check DLFNX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JMUAX has a market cap of 6.9B. Regarding current trading prices, CDC is priced at $71.08, while JMUAX trades at $8.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JMUAX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JMUAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JMUAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JMUAX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JMUIX has a market cap of 6.9B. Regarding current trading prices, CDC is priced at $71.08, while JMUIX trades at $8.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JMUIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JMUIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JMUIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JMUIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JMUCX has a market cap of 6.9B. Regarding current trading prices, CDC is priced at $71.08, while JMUCX trades at $8.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JMUCX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JMUCX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JMUCX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JMUCX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JMTNX has a market cap of 6.8B. Regarding current trading prices, CDC is priced at $71.08, while JMTNX trades at $8.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JMTNX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JMTNX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JMTNX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JMTNX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JMUTX has a market cap of 6.8B. Regarding current trading prices, CDC is priced at $71.08, while JMUTX trades at $8.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JMUTX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JMUTX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JMUTX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JMUTX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JMUSX has a market cap of 6.8B. Regarding current trading prices, CDC is priced at $71.08, while JMUSX trades at $8.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JMUSX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JMUSX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JMUSX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JMUSX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, TGIHX has a market cap of 6.8B. Regarding current trading prices, CDC is priced at $71.08, while TGIHX trades at $14.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas TGIHX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to TGIHX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TGIHX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check TGIHX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, TWEIX has a market cap of 6.6B. Regarding current trading prices, CDC is priced at $71.08, while TWEIX trades at $8.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas TWEIX's P/E ratio is 19.48. In terms of profitability, CDC's ROE is +0.00%, compared to TWEIX's ROE of +0.35%. Regarding short-term risk, CDC is more volatile compared to TWEIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check TWEIX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, AEUDX has a market cap of 6.6B. Regarding current trading prices, CDC is priced at $71.08, while AEUDX trades at $8.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas AEUDX's P/E ratio is 19.50. In terms of profitability, CDC's ROE is +0.00%, compared to AEUDX's ROE of +0.35%. Regarding short-term risk, CDC is more volatile compared to AEUDX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check AEUDX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JMTG has a market cap of 6.6B. Regarding current trading prices, CDC is priced at $71.08, while JMTG trades at $50.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JMTG's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JMTG's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to JMTG. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JMTG's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, DIVO has a market cap of 6.5B. Regarding current trading prices, CDC is priced at $71.08, while DIVO trades at $45.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas DIVO's P/E ratio is 23.87. In terms of profitability, CDC's ROE is +0.00%, compared to DIVO's ROE of +0.00%. Regarding short-term risk, CDC is less volatile compared to DIVO. This indicates potentially lower risk in terms of short-term price fluctuations for CDC.Check DIVO's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, TAIFX has a market cap of 6.4B. Regarding current trading prices, CDC is priced at $71.08, while TAIFX trades at $16.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas TAIFX's P/E ratio is 24.92. In terms of profitability, CDC's ROE is +0.00%, compared to TAIFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TAIFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check TAIFX's competition here

CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CDC stands at 751.1M. In comparison, JMST has a market cap of 6.2B. Regarding current trading prices, CDC is priced at $71.08, while JMST trades at $51.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CDC currently has a P/E ratio of 17.40, whereas JMST's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JMST's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to JMST. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.Check JMST's competition here